Product Images Apretude

View Photos of Packaging, Labels & Appearance

structural formula of cabotegravir - apretude spl graphic 01
Figure 1. Cumulative Incidence of HIV-1 Infections in HPTN 083 - apretude spl graphic 02
Figure 2. Cumulative Incidence of HIV-1 Infections in HPTN 084 - apretude spl graphic 03
Instructions for Use header - apretude spl graphic 04
storage information - apretude spl graphic 05
Kit contents - apretude spl graphic 06
Figure A - apretude spl graphic 07
Figure B - apretude spl graphic 08
Figure C - apretude spl graphic 09
Figure D - apretude spl graphic 10
Figure E - apretude spl graphic 11
Figure F - apretude spl graphic 12
Figure G - apretude spl graphic 13
Figure H - apretude spl graphic 14
Figure I - apretude spl graphic 15
Figure J - apretude spl graphic 16
Figure K - apretude spl graphic 17
Figure L - apretude spl graphic 18
Figure M - apretude spl graphic 19
Figure N - apretude spl graphic 20
Figure O - apretude spl graphic 21
Figure P - apretude spl graphic 22
Figure Q - apretude spl graphic 23
Figure R - apretude spl graphic 24
Figure S - apretude spl graphic 25
Apretude 3 mL kit carton - apretude spl graphic 26

Product Label Images

The following 26 images provide visual information about the product associated with Apretude NDC 49702-264 by Viiv Healthcare Company, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structural formula of cabotegravir - apretude spl graphic 01

Figure 1. Cumulative Incidence of HIV-1 Infections in HPTN 083 - apretude spl graphic 02

Figure 2. Cumulative Incidence of HIV-1 Infections in HPTN 084 - apretude spl graphic 03

Instructions for Use header - apretude spl graphic 04

INSTRUCTIONS FOR USE: "Pretude" is an extended-release injectable suspension with 600 mg/3 mL dosage (200 mg/mL). It is intended for intramuscular use only in the gluteal region of the body.*

storage information - apretude spl graphic 05

Kit contents - apretude spl graphic 06

The text describes a medical device called "APRETUDE vial Vial adapter" that includes a vial cap with a rubber stopper underneath. The device also involves a syringe with an injection needle, a plunger, a needle guard, and a needle cap.*

Figure A - apretude spl graphic 07

This text is a simple reminder to check the expiration date of medicine before use.*

Figure B - apretude spl graphic 08

Figure C - apretude spl graphic 09

Figure D - apretude spl graphic 10

Figure E - apretude spl graphic 11

Figure F - apretude spl graphic 12

Figure G - apretude spl graphic 13

Figure H - apretude spl graphic 14

Figure I - apretude spl graphic 15

Figure J - apretude spl graphic 16

Figure K - apretude spl graphic 17

Figure L - apretude spl graphic 18

Figure M - apretude spl graphic 19

Figure N - apretude spl graphic 20

Figure O - apretude spl graphic 21

Figure P - apretude spl graphic 22

Figure Q - apretude spl graphic 23

Figure R - apretude spl graphic 24

Figure S - apretude spl graphic 25

Not available.*

Apretude 3 mL kit carton - apretude spl graphic 26

Apretude is a prescription medication for healthcare professional administration only. It is an injectable suspension containing 600 mg/3 mL cabotegravir extended-release. It should only be administered into the gluteal muscle, using the vial adapter, syringe, and 23 gauge, 1% inch injection needle provided. Prescribing information, patient information, and instructions for use are also included. The National Drug Code for this medication is 49702-264-23.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.

Table of Contents